Grufity logoGrufity logo
StocksFundsSearch Filings

Carlyle Group Inc (The) Stock Research

CG

28.79USD+0.70(+2.49%)Delayed

Market Summary

USD28.79+0.70
Delayed
2.49%

CG Stock Price

CG RSI Chart

CG Valuation

Market Cap

10.4B

Price/Earnings (Trailing)

8.11

Price/Sales (Trailing)

2.81

EV/EBITDA

7.38

Price/Free Cashflow

-64.62

CG Price/Sales (Trailing)

CG Profitability

EBT Margin

35.43%

Return on Equity

18.83%

Return on Assets

6%

Free Cashflow Yield

-1.55%

CG Fundamentals

CG Revenue

Revenue (TTM)

3.7B

Revenue Y/Y

-64.01%

Revenue Q/Q

-33.91%

CG Earnings

Earnings (TTM)

1.3B

Earnings Y/Y

-75.98%

Earnings Q/Q

-43.84%

Price Action

52 Week Range

24.3239.93
(Low)(High)

Last 7 days

3.0%

Last 30 days

-3.2%

Last 90 days

-18.9%

Trailing 12 Months

-25.9%

CG Financial Health

Debt/Equity

0.33

Debt/Cashflow

-0.17

CG Investor Care

Shares Dilution (1Y)

0.11%

Diluted EPS (TTM)

2.07

Peers (Alternatives to Carlyle Group The)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
63.4B
4.8B
7.19% -24.55%
102.89
13.29
-62.27% -88.42%
46.2B
7.8B
4.52% -4.01%
-103.87
5.89
-64.76% -115.12%
33.8B
14.5B
8.96% 14.63%
10.39
2.44
5.75% -28.18%
12.5B
7.9B
-0.48% -4.54%
14.76
1.59
-9.17% -55.48%
MID-CAP
7.8B
5.8B
-7.29% -18.95%
11.43
1.29
-14.95% -52.29%
5.7B
737.1M
3.32% 4.39%
47.36
7.78
-67.95% -74.36%
5.4B
2.3B
3.50% 8.76%
4.75
2.34
-3.43% 102.56%
4.8B
2.6B
5.19% 0.93%
10.01
1.72
-21.95% -46.68%
4.5B
2.1B
3.49% 0.13%
16.45
2.17
-24.19% -55.18%
3.2B
2.7B
5.04% -12.41%
8.95
1.12
-18.40% -60.07%
2.1B
646.6M
0.45% 37.25%
21.79
3.31
15.54% 72.98%
SMALL-CAP
514.3M
146.2M
6.74% -5.35%
11.68
3.52
-21.14% -36.78%
457.1M
40.1M
3.86% -32.32%
25.62
11.4
-0.04% -31.55%
206.6M
434.9M
5.89% -21.08%
82.34
0.37
-27.53% -139.58%
161.6M
197.7M
0.84% -7.62%
4
0.82
5.01% -33.91%

Financials for Carlyle Group The

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Revenue-16.3%3,7164,4395,7186,2697,927
  S&GA Expenses9.2%629576519469446
Costs and Expenses-4.9%2,6862,8253,3503,5894,314
EBITDA-28.0%1,8302,5432,8583,782-
EBITDA Margin-7.3%0.41*0.44*0.46*0.48*-
Earnings Before Taxes-37.1%9891,5732,3102,6533,606
EBT Margin-12.3%0.35*0.40*0.42*0.45*-
Interest Expenses1.7%112110119120118
Net Income-28.1%1,2851,7872,0522,749-
Net Income Margin-7.4%0.29*0.31*0.32*0.34*-
Free Cahsflow-320.2%-4191915961,306-
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Assets-0.6%21,27421,40321,09221,42521,736
    Cash Equivalents-24.5%1,0271,3611,3621,3091,290
  Net PPE1.4%142140134138145
  Goodwill711.0%10313.0013.00--
Liabilities-0.8%14,46214,58214,43814,99315,382
  Long Term Debt-0.2%2,2352,2392,255--
    LT Debt, Non Current-0.2%2,2352,2392,255--
Shareholder's Equity-0.1%6,8126,8216,6556,4326,354
  Retained Earnings-3.5%3,2813,4013,4313,3103,207
  Additional Paid-In Capital1.8%3,1963,1393,1233,0342,982
Shares Outstanding-0.1%362362363361362
Minority Interest6.1%637600537446444
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Cashflow From Operations68.3%-120-3792306371,350
  Share Based Compensation9.5%169154180169170
Cashflow From Investing64.8%-292-828-877-656-653
Cashflow From Financing24.4%143115-311-236-255
  Dividend Payments6.5%473444415386357
  Buy Backs10.7%206186224242232

Risks for CG

What is the probability of a big loss on CG?

73.8%


Probability that Carlyle Group The stock will be more than 20% underwater in next one year

56.9%


Probability that Carlyle Group The stock will be more than 30% underwater in next one year.

33.9%


Probability that Carlyle Group The stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CG drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Carlyle Group The was unfortunately bought at previous high price.

Drawdowns

Returns for CG

Cumulative Returns on CG

6.4%


10-Year Cumulative Returns

14.2%


7-Year Cumulative Returns

9.2%


5-Year Cumulative Returns

2.4%


3-Year Cumulative Returns

What are the long-term rolling returns for CG?

FIve years rolling returns for Carlyle Group The.

Annualized Returns

Which funds bought or sold CG recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-06-01
MACQUARIE GROUP LTD
added
16.39
447,737
2,566,480
-%
2023-05-26
ProShare Advisors LLC
sold off
-100
-497,463
-
-%
2023-05-23
ROYCE & ASSOCIATES LP
added
18.52
572,250
3,021,520
0.03%
2023-05-23
Brookfield Corp /ON/
reduced
-29.64
-1,862,040
5,096,200
0.02%
2023-05-23
Toroso Investments, LLC
added
93.36
499,000
992,000
0.02%
2023-05-22
PUTNAM INVESTMENTS LLC
reduced
-10.11
-1,025,360
14,903,000
0.02%
2023-05-22
AMERIPRISE FINANCIAL INC
added
3,186
99,120,000
102,104,000
0.03%
2023-05-22
Arete Wealth Advisors, LLC
reduced
-1.43
-397,318,000
408,000
0.03%
2023-05-18
NEW YORK STATE COMMON RETIREMENT FUND
reduced
-5.72
-224,000
11,805,000
0.02%
2023-05-18
JPMORGAN CHASE & CO
reduced
-16.37
-1,838,560
12,364,400
-%

1–10 of 41

Latest Funds Activity

Are funds buying CG calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CG
No. of Funds

Carlyle Group The News

Simply Wall St
Carlyle Group's (NASDAQ:CG) investors will be pleased with their notable 75% return over the last three years.
Simply Wall St,
2 months ago
The Business Journals
Nasdaq
The Business Journals

Schedule 13G FIlings of Carlyle Group The

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
capital world investors
0.6%
2,217,000
SC 13G/A
Feb 09, 2023
vanguard group inc
6.86%
24,952,869
SC 13G/A
Feb 08, 2023
morgan stanley
6.4%
23,412,646
SC 13G/A
Jun 14, 2022
carlyle group management l.l.c.
42.1%
152,131,004
SC 13D/A
Feb 14, 2022
vulcan value partners, llc
4.66%
16,609,123
SC 13G/A
Feb 11, 2022
conway william e jr
9.0%
31,999,644
SC 13G/A
Feb 11, 2022
capital world investors
5.4%
19,315,259
SC 13G
Feb 11, 2022
d'aniello daniel a.
9.3%
32,999,644
SC 13G/A
Feb 11, 2022
rubenstein david m.
8.8%
31,249,644
SC 13G/A
Feb 10, 2022
morgan stanley
5.1%
18,224,322
SC 13G

CG Fair Value

Show Fair-Value

Recent SEC filings of Carlyle Group The

View All Filings
Date Filed Form Type Document
Jun 02, 2023
8-K
Current Report
May 25, 2023
4
Insider Trading
May 10, 2023
4
Insider Trading
May 10, 2023
4
Insider Trading
May 10, 2023
SC 13D/A
13D - Major Acquisition
May 09, 2023
SC 13D/A
13D - Major Acquisition
May 05, 2023
13F-HR
Fund Holdings Report
May 04, 2023
10-K/A
Annual Report
May 04, 2023
8-K
Current Report
May 04, 2023
10-Q
Quarterly Report

Latest Insider Trading transactions for CG

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-05-23
SCHWARTZ HARVEY M
acquired
-
-
85,723
chief executive officer
2023-05-01
FITT LAWTON W
acquired
-
-
6,238
-
2023-05-01
ORDAN MARK S
acquired
-
-
6,238
-
2023-05-01
ROBERTSON THOMAS S
acquired
-
-
6,238
-
2023-05-01
SHAW WILLIAM JOSEPH
acquired
-
-
6,238
-
2023-05-01
WELTERS ANTHONY
acquired
-
-
6,238
-
2023-05-01
HANCE JAMES H JR
acquired
-
-
6,238
-
2023-05-01
Rice Derica W
acquired
-
-
6,238
-
2023-05-01
FILLER LINDA
acquired
-
-
6,238
-
2023-03-01
SCHWARTZ HARVEY M
acquired
-
-
63,849
chief executive officer

1–10 of 50

Kewsong Lee
1850
The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, South East Asia, Indonesia, Philippines, Vietnam, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations a

CG Income Statement

2023-03-31
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues  
Investment income$ 172,500,000$ 1,029,800,000
Interest and other income44,000,000.025,800,000
Interest and other income of Consolidated Funds121,900,00061,700,000
Total revenues859,000,000.01,581,800,000
Compensation and benefits  
Cash-based compensation and benefits260,200,000254,300,000
Equity-based compensation54,400,00039,700,000
Performance allocations and incentive fee related compensation105,700,000370,700,000
Total compensation and benefits420,300,000664,700,000
General, administrative and other expenses159,200,000106,300,000
Interest29,700,00027,800,000
Interest and other expenses of Consolidated Funds93,700,00042,800,000
Other non-operating expenses100,000300,000
Total expenses703,000,000.0841,900,000
Other income  
Net investment income of Consolidated Funds3,600,0002,800,000
Income before provision for income taxes159,600,000742,700,000
Provision for income taxes34,300,000147,900,000
Net income125,300,000594,800,000
Net income attributable to non-controlling interests in consolidated entities24,600,00023,200,000
Net income attributable to common shares$ 100,700,000$ 571,600,000
Net income attributable to The Carlyle Group Inc. per common share (see Note 12)  
Basic (in dollars per share)$ 0.28$ 1.60
Diluted (in dollars per share)$ 0.28$ 1.57
Weighted-average common shares  
Basic (in shares)362,944,260357,574,838
Diluted (in shares)365,357,833363,010,282
Fund management fees  
Revenues  
Fund management fees and incentive fees$ 500,800,000$ 450,500,000
Incentive fees  
Revenues  
Fund management fees and incentive fees19,800,00014,000,000.0
Performance allocations  
Revenues  
Investment income160,800,000710,200,000
Principal investment income  
Revenues  
Investment income$ 11,700,000$ 319,600,000

CG Balance Sheet

2023-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Assets  
Cash and cash equivalents$ 1,010.1$ 1,360.7
Cash and cash equivalents held at Consolidated Funds228.8209.0
Restricted cash16.80.8
Corporate treasury investments102.020.0
Investments, including accrued performance allocations of $7,134.0 million and $7,117.7 million as of March 31, 2023 and December 31, 2022, respectively10,784.110,767.9
Investments of Consolidated Funds7,067.36,894.4
Due from affiliates and other receivables, net499.3579.4
Due from affiliates and other receivables of Consolidated Funds, net100.6101.9
Fixed assets, net141.8139.9
Lease right-of-use assets, net331.5337.0
Deposits and other111.178.4
Intangible assets, net866.4897.8
Deferred tax assets14.115.8
Total assets21,273.921,403.0
Liabilities and equity  
Debt obligations2,275.62,271.7
Loans payable of Consolidated Funds6,085.95,905.2
Accounts payable, accrued expenses and other liabilities304.8369.2
Accrued compensation and benefits3,894.24,320.9
Due to affiliates314.1362.5
Deferred revenue411.7126.4
Deferred tax liabilities389.5402.7
Other liabilities of Consolidated Funds250.8279.3
Lease liabilities494.9502.9
Accrued giveback obligations40.940.9
Total liabilities14,462.414,581.7
Commitments and contingencies
Common stock, $0.01 par value, 100,000,000,000 shares authorized (362,056,444 and 362,298,650 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively)3.63.6
Additional paid-in-capital3,195.53,138.5
Retained earnings3,280.93,401.1
Accumulated other comprehensive loss(305.2)(322.2)
Non-controlling interests in consolidated entities636.7600.3
Total equity6,811.56,821.3
Total liabilities and equity$ 21,273.9$ 21,403.0